Feasibility of ApoC1 serum levels as tumor biomarker in glioblastoma patients: a pilot study

Apolipoprotein C1 (ApoC1) has been detected immunohistochemically in glioblastoma tissue, probably expressed by activated monocytes and microglia. The present study was conceived to determine whether the amount of intratumoral ApoC1 expression leads to measurable changes of serum levels after gliobl...

Descripción completa

Detalles Bibliográficos
Autores principales: Hilbert, Michelle, Kuzman, Peter, Mueller, Wolf C., Meixensberger, Jürgen, Nestler, Ulf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9550816/
https://www.ncbi.nlm.nih.gov/pubmed/36216850
http://dx.doi.org/10.1038/s41598-022-21216-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9550816/
https://www.ncbi.nlm.nih.gov/pubmed/36216850
http://dx.doi.org/10.1038/s41598-022-21216-1

Ejemplares similares